Changing Paradigms—An Update on the Multidisciplinary Management of Malignant Glioma
Open Access
- 1 February 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 11 (2) , 165-180
- https://doi.org/10.1634/theoncologist.11-2-165
Abstract
Learning Objectives: After completing this course, the reader will be able to: List the different major subtypes of glioma and identify the appropriate treatment strategies for patients with high-grade and low-grade gliomas.Discuss the available evidence for the treatment of newly diagnosed glioblastoma, anaplastic astrocytoma, and anaplastic oligodendroglioma.Identify approved agents and other active or investigational agents used to treat patients with newly diagnosed and recurrent glioma. CME Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.comKeywords
This publication has 109 references indexed in Scilit:
- Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Clinical Cancer Research, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Selective CD4+ Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic ImplicationsJournal of Clinical Oncology, 2004
- Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesBritish Journal of Cancer, 2003
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- In vitro evaluation of temozolomide combined with X-irradiationAnti-Cancer Drugs, 1997
- Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiationActa Neurochirurgica, 1994
- O6-Alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implicationsJournal of Neuro-Oncology, 1994
- Phase II study of fotemustine in recurrent supratentorial malignant gliomasEuropean Journal of Cancer and Clinical Oncology, 1991
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980